The U.S. House of Representatives last night passed a sweeping healthcare package that would require 340B providers to publicly report [...] …
Category: Providers
Months after it was expected, bipartisan legislation to prevent drugmaker restrictions on the use of contract pharmacies by 340B providers [...] …
A Missouri state senator has filed to reintroduce a bill that would bar drugmaker 340B contract pharmacy restrictions and pharmacy [...] …
Just a week after Wisconsin state senators introduced a bipartisan bill to bar disparate treatment of 340B providers by pharmacy [...] …
Pharmaceutical company executives discussed a range of 340B-related developments in recent third quarter investor calls. An executive for BioMarin Pharmaceutical, [...] …
Lawmakers on a key House committee approved a pharmacy benefit manager (PBM) transparency bill on Wednesday that would require PBMs [...] …
Critical access hospitals (CAHs) and Ryan White HIV/AIDS clinics do not expect problems implementing a new requirement starting Jan. 1, [...] …
Federal auditors determined terminations from the 340B program were required for either covered entity sites or contract pharmacies of four [...] …
Biopharmaceutical manufacturer Biogen recently expanded its contract pharmacy restrictions for hospitals to a third drug, after that medication garnered a [...] …
The 340B program has become “a multibillion-dollar boondoggle for hospital mega-chains” and needs reform, says Howard Dean, a one-time Democratic [...] …